Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|18|6|665-667
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.18, Iss.6, 2018-11, pp. : 665-667
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tocilizumab dominates adalimumab for severe RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 669, 2013-01 ,pp. :
Is tocilizumab an option for the treatment of arthritis?
Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 11, 2008-08 ,pp. :
Treatment of severe malaria with artemether is not associated with neurotoxic effects
Inpharma, Vol. 1, Iss. 1398, 2003-01 ,pp. :